Vinmec a pioneer in applying screening gene testing technology for type 2 diabetes risk
Early screening gene testing of diabetes risk is a product between Vinmec Health System and DNA Link - one of South Korea's leading companies in researching and developing biomedical and genetic analysing technology. The test was first applied at Vinmec, to help to screen for type 2 diabetes, recommended for people who suffer prediabetes or who have already had diabetes for the most effective treatment regimen.